Prostate cancer
Results
Phase 1
This study looked at two vaccines called ChAdOx1.5T4 and MVA.5T4, with or without chemotherapy.
It was for men who were due to have surgery to remove their prostate cancer or who were having active surveillance. Active surveillance means having regular tests and check ups, and having treatment if the cancer starts to grow.
The study was open for people to join between 2015 and 2017. The team published the results in 2020.
Recruitment start: 1 July 2015
Recruitment end: 31 January 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Freddie Hamdy
Experimental Cancer Medicine Centre (ECMC)
European Commission
NIHR Clinical Research Network: Cancer
University of Oxford
Last reviewed: 20 Aug 2023
CRUK internal database number: 13025
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
